suPAR and chronic kidney disease-a podocyte story

被引：38

作者：

Zeier, Martin ^{[1
]}

Reiser, Jochen ^{[2
]}

机构：

[1] Heidelberg Univ, Div Nephrol, Heidelberg, Germany

[2] Rush Univ, Med Ctr, Dept Med, Kellogg Bldg,Suite 1003, Chicago, IL 60612 USA

来源：

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2017年 / 469卷 / 7-8期

关键词：

suPAR; Integrin; Podocyte; FSGS; CKD; PLASMINOGEN-ACTIVATOR RECEPTOR; SOLUBLE UROKINASE RECEPTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CIRCULATING SUPAR; GLOMERULAR-FILTRATION; PROTEINURIA; PROGRESSION; DIET;

D O I：

10.1007/s00424-017-2026-7

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

The soluble urokinase-type plasminogen activator receptor (suPAR) is a circulating signaling molecule derived from immature myeloid cells. Elevated levels of suPAR have been linked to the pathogenesis of the kidney disease focal and segmental glomerulosclerosis. Here, suPAR acts on podocytes by activating alpha v beta 3 integrins. Large observational studies showed that suPAR also predicts chronic kidney disease incidence and progression by predating the disease by several years prior to any other known marker of renal dysfunction. suPAR is rapidly developing into a prime target for pharmacotherapy as its neutralization is forecasted to be feasible and safe.

引用

页码：1017 / 1020

页数：4

共 50 条

[31] A suPAR circulating factor causes kidney disease
Stuart J Shankland
Martin R Pollak
[J]. Nature Medicine, 2011, 17 : 926 - 927
[32] Anemia of Chronic Kidney Disease-A Narrative Review of Its Pathophysiology, Diagnosis, and Management
Badura, Krzysztof
Janc, Jedrzej
Wasik, Joanna
Gnitecki, Szymon
Skwira, Sylwia
Mlynarska, Ewelina
Rysz, Jacek
Franczyk, Beata
[J]. BIOMEDICINES, 2024, 12 (06)
[33] Renalase in chronic kidney disease: the evolving story reply
Wisniewska, Magda
Dziedziejko, Violetta
Safranow, Krzysztof
Pawlik, Andrzej
[J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (01): : 90 - 90
[34] Screening for kidney disease-a lost opportunity
Molitoris, Bruce A.
[J]. NATURE REVIEWS NEPHROLOGY, 2014, 10 (01) : 6 - 8
[35] Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease
Li, Han
Fu, Yingjie
Xu, Yue
Miao, Hongjun
Wang, Haonan
Zhang, Tongtong
Mei, Xuejian
He, Yinglang
Zhang, Aihua
Ge, Xuhua
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2024, 327 (02): : C254 - C269
[36] Atrial Fibrillation and Chronic Kidney Disease-A Risky Combination for Post-Contrast Acute Kidney Injury
Kuzma, Lukasz
Tomaszuk-Kazberuk, Anna
Kurasz, Anna
Zalewska-Adamiec, Malgorzata
Bachorzewska-Gajewska, Hanna
Dobrzycki, Slawomir
Kwiatkowska, Marlena
Malyszko, Jolanta
[J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
[37] Podocyte lipotoxicity in diabetic kidney disease
Nishi, Hiroshi
Nangaku, Masaomi
[J]. KIDNEY INTERNATIONAL, 2019, 96 (04) : 809 - 812
[38] POLYCYSTIC KIDNEY DISEASE Progression of polycystic kidney disease-a lack of progress?
McDonald, Stephen
Rangan, Gopala
[J]. NATURE REVIEWS NEPHROLOGY, 2014, 10 (09) : 489 - 491
[39] Podocyte Biology and Pathogenesis of Kidney Disease
Reiser, Jochen
Sever, Sanja
[J]. ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 357 - 366
[40] Treatment Patterns in Type 2 Diabetes Patients with Chronic Kidney Disease-A Cohort Study
Blankenburg, Michael
Kovesdy, Csaba P.
Eisenring, Seline
Fett, Anne
Schokker, Emile W.
Korn, Jonathan
Gay, Alain
[J]. DIABETES, 2018, 67

← 1 2 3 4 5 →